نتائج البحث 71-80 من 10790 لعملية البحث عن Vaginal%2Bcancer
... women with stage I-III breast cancer stay on their hormone therapy medicines. ... 2 Dose (RP2D) in patients with HCC and ICC who ... carcinoma (HCC). The ...
... cancer (TNBC) or non-small cell lung cancer (NSCLC). ... Uterine Leiomyosarcoma. Scottsdale/Phoenix ... 2b (NaPi2b) expressing platinum-resistant high ...
A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer ... (2) Cohort 2 focuses on primary or ...
Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...
To achieve this shorter course, proton therapy is used. This study aims to determine cancer control at 2 years after study registration. It also aims to ...
A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol ... (2) Cohort 2 focuses on ...
In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...
... 2B (Dose Expansion) with Cohort D1 (monotherapy SAR444881). A Study of Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples. Rochester, Minn ...
... cancer (CRC) disease, to evaluate the use of PDOs as a new personalized ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...
... 2 or 3 meningioma as measured by 6-month PFS rate. ... The purpose of this study is to develop a biorepository of blood samples from cancer patients participating ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.